BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

810 related articles for article (PubMed ID: 31269423)

  • 41. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity.
    Xie Y; Zhu S; Song X; Sun X; Fan Y; Liu J; Zhong M; Yuan H; Zhang L; Billiar TR; Lotze MT; Zeh HJ; Kang R; Kroemer G; Tang D
    Cell Rep; 2017 Aug; 20(7):1692-1704. PubMed ID: 28813679
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Beclin1-mediated ferroptosis activation is associated with isoflurane-induced toxicity in SH-SY5Y neuroblastoma cells.
    Liu R; Li X; Zhao G
    Acta Biochim Biophys Sin (Shanghai); 2019 Nov; 51(11):1134-1141. PubMed ID: 31650158
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Autophagy promotes ferroptosis by degradation of ferritin.
    Hou W; Xie Y; Song X; Sun X; Lotze MT; Zeh HJ; Kang R; Tang D
    Autophagy; 2016 Aug; 12(8):1425-8. PubMed ID: 27245739
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Why should neuroscientists worry about iron? The emerging role of ferroptosis in the pathophysiology of neuroprogressive diseases.
    Morris G; Berk M; Carvalho AF; Maes M; Walker AJ; Puri BK
    Behav Brain Res; 2018 Apr; 341():154-175. PubMed ID: 29289598
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The release and activity of HMGB1 in ferroptosis.
    Wen Q; Liu J; Kang R; Zhou B; Tang D
    Biochem Biophys Res Commun; 2019 Mar; 510(2):278-283. PubMed ID: 30686534
    [TBL] [Abstract][Full Text] [Related]  

  • 46. FINO
    Gaschler MM; Andia AA; Liu H; Csuka JM; Hurlocker B; Vaiana CA; Heindel DW; Zuckerman DS; Bos PH; Reznik E; Ye LF; Tyurina YY; Lin AJ; Shchepinov MS; Chan AY; Peguero-Pereira E; Fomich MA; Daniels JD; Bekish AV; Shmanai VV; Kagan VE; Mahal LK; Woerpel KA; Stockwell BR
    Nat Chem Biol; 2018 May; 14(5):507-515. PubMed ID: 29610484
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ferroptosis as a target for protection against cardiomyopathy.
    Fang X; Wang H; Han D; Xie E; Yang X; Wei J; Gu S; Gao F; Zhu N; Yin X; Cheng Q; Zhang P; Dai W; Chen J; Yang F; Yang HT; Linkermann A; Gu W; Min J; Wang F
    Proc Natl Acad Sci U S A; 2019 Feb; 116(7):2672-2680. PubMed ID: 30692261
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Necroptosis and ferroptosis are alternative cell death pathways that operate in acute kidney failure.
    Müller T; Dewitz C; Schmitz J; Schröder AS; Bräsen JH; Stockwell BR; Murphy JM; Kunzendorf U; Krautwald S
    Cell Mol Life Sci; 2017 Oct; 74(19):3631-3645. PubMed ID: 28551825
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of tumor microenvironment on ferroptosis: inhibition or promotion.
    Xia Z; Quan Y
    Front Oncol; 2023; 13():1155511. PubMed ID: 37213276
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effective combinatorial immunotherapy for castration-resistant prostate cancer.
    Lu X; Horner JW; Paul E; Shang X; Troncoso P; Deng P; Jiang S; Chang Q; Spring DJ; Sharma P; Zebala JA; Maeda DY; Wang YA; DePinho RA
    Nature; 2017 Mar; 543(7647):728-732. PubMed ID: 28321130
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Ferroptosis: Yet Another Way to Die.
    Kazan K; Kalaipandian S
    Trends Plant Sci; 2019 Jun; 24(6):479-481. PubMed ID: 30910286
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Ferroptosis-inducing agents compromise in vitro human islet viability and function.
    Bruni A; Pepper AR; Pawlick RL; Gala-Lopez B; Gamble AF; Kin T; Seeberger K; Korbutt GS; Bornstein SR; Linkermann A; Shapiro AMJ
    Cell Death Dis; 2018 May; 9(6):595. PubMed ID: 29789532
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Self-assembled nano-activator constructed ferroptosis-immunotherapy through hijacking endogenous iron to intracellular positive feedback loop.
    Xiong H; Wang C; Wang Z; Lu H; Yao J
    J Control Release; 2021 Apr; 332():539-552. PubMed ID: 33689796
    [TBL] [Abstract][Full Text] [Related]  

  • 54. FANCD2 protects against bone marrow injury from ferroptosis.
    Song X; Xie Y; Kang R; Hou W; Sun X; Epperly MW; Greenberger JS; Tang D
    Biochem Biophys Res Commun; 2016 Nov; 480(3):443-449. PubMed ID: 27773819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell growth potential drives ferroptosis susceptibility in rhabdomyosarcoma and myoblast cell lines.
    Codenotti S; Poli M; Asperti M; Zizioli D; Marampon F; Fanzani A
    J Cancer Res Clin Oncol; 2018 Sep; 144(9):1717-1730. PubMed ID: 29971532
    [TBL] [Abstract][Full Text] [Related]  

  • 56. How do we fit ferroptosis in the family of regulated cell death?
    Fearnhead HO; Vandenabeele P; Vanden Berghe T
    Cell Death Differ; 2017 Dec; 24(12):1991-1998. PubMed ID: 28984871
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD4+ T cells induce rejection of urothelial tumors after immune checkpoint blockade.
    Sato Y; Bolzenius JK; Eteleeb AM; Su X; Maher CA; Sehn JK; Arora VK
    JCI Insight; 2018 Dec; 3(23):. PubMed ID: 30518683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders.
    Wu JR; Tuo QZ; Lei P
    J Mol Neurosci; 2018 Oct; 66(2):197-206. PubMed ID: 30145632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of ferritinophagy is required for the RNA-binding protein ELAVL1/HuR to regulate ferroptosis in hepatic stellate cells.
    Zhang Z; Yao Z; Wang L; Ding H; Shao J; Chen A; Zhang F; Zheng S
    Autophagy; 2018; 14(12):2083-2103. PubMed ID: 30081711
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Cancer immunotherapy: Macs in the middle.
    Shoukry NH; Turcotte S
    Immunity; 2021 Mar; 54(3):409-411. PubMed ID: 33691132
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.